Implications of antineutrophil cytoplasmic antibody status when switching to maintenance therapy.
Hoffman
Gary S
GS
Stone
John H
JH
Langford
Carol
C
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans
D019268:Antibodies, Antineutrophil Cytoplasmic; D018501:Antirheumatic Agents